Pharmacotherapeutic follow-up in patients with arthrosis in a private pharmaceutical office
DOI:
https://doi.org/10.15381/ci.v25i2.24862Keywords:
Osteoarthritis, Pharmacotherapeutic Follow-up, Drug-Related Problem (DRP)Abstract
The objective of this study was to carry out pharmacotherapeutic follow-up (SFT) in patients with osteoarthritis, evaluating the level of knowledge, pharmacotherapeutic adherence, identification of drug-related problem (DRP) and quality of life. It is a descriptive, observational and longitudinal study in twenty patients diagnosed with osteoarthritis. The data collection, from the patients recruited in a private pharmaceutical office, was carried out by means of instruments that consist of the formulation of surveys carried out in the patient’s home. The predominant sex was female (90%) and an age range of 56 to 60 years (40%), with comorbidities being arterial hypertension (45%), osteoporosis and diabetes mellitus, the average of the intensity measurement scale pain was reduced by 2 points (p<0.05) and quality of life improved (p<0.05). The level of knowledge about osteoarthritis was rated before and after the study, who managed to increase after the study to 18 patients (95% good rating). 90% of patients were non-adherent to treatment; the SFT was able to identify 57 PRM, the PRM 1 of necessity prevailed, which in 18 patients do not receive the medication they need, followed by the PRM 5, where 15 people suffer a health problem as a result of a non-quantitative insecurity of a drug and PRM 2. It is concluded that pharmacotherapeutic follow-up through pharmaceutical intervention has a positive impact on patients with osteoarthritis.
Downloads
Published
Issue
Section
License
Copyright (c) 2022 Corina Flores Julián, Norma Ramos Cevallos, Martin Condorhuamán Figueroa
This work is licensed under a Creative Commons Attribution 4.0 International License.
LOS AUTORES RETIENEN SUS DERECHOS:
- Los autores retienen sus derechos de marca y patente, y tambien sobre cualquier proceso o procedimiento descrito en el artículo.
- Los autores retienen el derecho de compartir, copiar, distribuir, ejecutar y comunicar públicamente el articulo publicado en la Revista Ciencia e Investigación (por ejemplo, colocarlo en un repositorio institucional o publicarlo en un libro), con un reconocimiento de su publicación inicial en la Revista Ciencia e Investigación.
- Los autores retienen el derecho a hacer una posterior publicación de su trabajo, de utilizar el artículo o cualquier parte de aquel (por ejemplo: una compilación de sus trabajos, notas para conferencias, tesis, o para un libro), siempre que indiquen la fuente de publicación (autores del trabajo, revista, volumen, numero y fecha).
